| Position 2007 (2006) | Company | No of R&D products 2007 (2006) | No of own products |
|---|---|---|---|
| 1 (2) | GlaxoSmithKline | 228 (181) | 156 |
| 2 (7) | Pfizer | 182 (109) | 137 |
| 3 (1) | Sanofi-Aventis | 180 (205) | 137 |
| 4 (5) | Novartis | 177 (123) | 108 |
| 5 (3) | Merck & Co | 167 (159) | 117 |
| 6 (4) | Hoffmann-La Roche | 130 (145) | 61 |
| 7 (8) | AstraZeneca | 122 (108) | 90 |
| 8 (11) | Wyeth | 110 (81) | 79 |
| 9 (6) | Johnson & Johnson | 99 (116) | 45 |
| 10 (-) | Bayer | 90 (-) | 50 |
| 11 (9) | Astellas | 88 (89) | 50 |
| 12 (10) | Bristol-Myers Squibb | 87 (81) | 50 |
| 13 (14) | Eli Lilly | 83 (69) | 54 |
| 14 (15) | Abbott | 75 (55) | 48 |
| 15 (12) | Daiichi Sankyo | 73 (80) | 45 |
| 16 (-) | Merck KGaA | 72 (-) | 24 |
| 17 (20) | Akzo Nobel | 66 (51) | 50 |
| 18 (18) | Amgen | 65 (52) | 45 |
| 19 (21) | Schering-Plough | 56 (50) | 24 |
| 20 (16) | Takeda | 54 (53) | 19 |
| 21 (22) | Genzyme | 49 (47) | 32 |
| 22 (19) | Solvay | 48 (52) | 31 |
| 23 (-) | Genentech | 47 (-) | 23 |
| 24 (25) | Eisai | 46 (37) | 28 |
| 25 (24) | Medarex | 45 (37) | 36 |
| Table 2 - Top 25 companies based on the number of products in their R&D pipelines | |||